RISS 검색 - 국내학술지논문

무료
기관 내 무료
유료

내보내기
내책장담기
한글로보기

정확도순

내림차순

내림차순

10개씩 출력

1
The Relationship among Perceptions of Green HRM, Green Work Climate, Employee Green Motivation, and Environmental Commitment: The Case of Bangladesh Textile Industry

Akter Afroza,이현응 중앙대학교 Human Engagement Institute 2023 역량개발학습연구 Vol.18 No.4
- 원문보기
- 복사/대출신청
As global concerns about environmental degradation and climate change intensify, green human resource management (GHRM) has emerged as a crucial strategic approach for organizations that are recognizing the need to align their human resource practices with sustainable, eco-friendly initiatives. In this study, it is proposed that GHRM affects employees’ environmental commitment by fostering a green work climate and enhancing their green motivation. To gather empirical evidence for this proposition, the researchers collected data from 201 Bangladeshi employees working in the textile industry, and conducted statistical analysis using structural equation modeling (SEM). The findings of the study are as follows: First, perceptions of GHRM had significant positive relationships with both perceived green work climate and employee green motivation. Second, perceived green work climate did not have a significant relationship with employee green motivation controlling for perceptions of GHRM. Third, both perceived green work climate and employee green motivation had positive relationships with environmental commitment. Fourth, both perceived green work climate and employee green motivation had significant mediating effects on the GHRM-environmental commitment relationship. Implications and suggestions are presented based on these findings.
2
Safety of the oral cholera vaccine in pregnancy: Retrospective findings from a subgroup following mass vaccination campaign in Dhaka, Bangladesh ☆

Khan, Ashraful Islam,Ali, Mohammad,Chowdhury, Fahima,Saha, Amit,Khan, Iqbal Ansary,Khan, Arifuzzaman,Akter, Afroza,Asaduzzaman, Muhammad,Islam, Md. Taufiqul,Kabir, Alamgir,You, Young Ae,Saha, Nirod Ch Elsevier Science 2017 Vaccine Vol.35 No.11
- 원문보기
<▼1>Highlights•Few women received the OCV unknowingly while pregnant during a large vaccine trial.•There is limited data on the safety of OCVs in pregnancy.•We evaluated the effect of a killed OCV, Shanchol™, on pregnancy outcomes.•Study showed no evidence of exposure to Shanchol™ on adverse pregnancy outcomes.</▼1><▼2>BackgroundPregnant women are vulnerable to complications of cholera. Killed oral cholera vaccines (OCV) are not recommended for pregnant women though there is no evidence of harmful effects during pregnancy. We evaluated the effect of a killed OCV, Shanchol™, on pregnancy outcomes during an effectiveness trial of the vaccine in urban Bangladesh.MethodologyIndividuals ⩾1 year were invited to participate in the trial, conducted in 2011 in Dhaka, Bangladesh. Pregnancy by history was an exclusion criterion and all women of reproductive age (15–49 years) were verbally questioned about pregnancy at enrollment and prior to vaccination. Out of 48,414 women of reproductive age 286 women received the OCV unknowingly while pregnant. Out of these, we could recruit 69 women defined as exposed to OCV. Accordingly, we selected 69 pregnant women randomly from those who did not take the OCV (non-exposed to OCV). We evaluated adverse pregnancy outcome (spontaneous miscarriages, still births, or congenital malformations) between those who were exposed to OCV and those who were not exposed to OCV.ResultsAbout 16% of pregnant women exposed to OCV had pregnancy loss, as compared to 12% of unvaccinated pregnant women (P = 0.38). One congenital anomaly was observed and occurred in women non-exposed to OCV group. Models that adjusted for baseline characteristics that were unbalanced between the exposed and non-exposed groups, revealed a no elevation of risk of adverse pregnancy outcomes in vaccinees versus non-vaccinees (Adj. OR (95% CI): 0.45 (0.11–1.88).ConclusionsNo excess of adverse fetal outcomes associated with receipt of OCV was observed in this study.Trial registration: Clinical Trials.gov number NCT01339845.</▼2>